← Evidence map

ReviewTherapeutics and clinical risk management2015

Update on the emerging role of telavancin in hospital-acquired infections.

Obinna N Nnedu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2015
2016
2017
2018
2019
2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25926737